indomethacin has been researched along with Duodenal Diseases in 6 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Duodenal Diseases: Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, M | 1 |
| Reichert, P | 1 |
| Cann, H | 1 |
| Meddings, JB | 1 |
| Sutherland, LR | 1 |
| Byles, NI | 1 |
| Wallace, JL | 1 |
| Stalnikowicz, R | 2 |
| Goldin, E | 2 |
| Fich, A | 2 |
| Wengrower, D | 2 |
| Eliakim, R | 1 |
| Ligumsky, M | 2 |
| Rachmilewitz, D | 2 |
| Pollak, D | 1 |
| Eliakim, A | 1 |
| Müller, P | 1 |
| Dammann, HG | 1 |
| Simon, B | 1 |
| Ewing, GO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| GpCRC Pediatric Gastroparesis Registry 2: Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants With Symptoms of Gastroparesis[NCT05981300] | 216 participants (Anticipated) | Observational [Patient Registry] | 2024-02-28 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for indomethacin and Duodenal Diseases
| Article | Year |
|---|---|
Indomethacin-induced gastroduodenal damage is not affected by cotreatment with ranitidine.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Synergism; Duodenal Diseases; Duodenum; Female; G | 1989 |
Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders.
Topics: Adolescent; Adult; Aged; Bone Diseases; Cimetidine; Clinical Trials as Topic; Double-Blind Method; D | 1988 |
[Gastroduodenal tolerability of indomethacin and acetaminophen. A comparative endoscopic study in healthy subjects].
Topics: Acetaminophen; Adult; Double-Blind Method; Drug Tolerance; Duodenal Diseases; Gastric Mucosa; Gastro | 1986 |
3 other studies available for indomethacin and Duodenal Diseases
| Article | Year |
|---|---|
Abrupt onset of abdominal pain. Duodenal perforation caused by indomethacin.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Duodenal Diseases; Humans; Indomethacin; In | 2013 |
Sucrose: a novel permeability marker for gastroduodenal disease.
Topics: Animals; Duodenal Diseases; Duodenum; Gastric Mucosa; Humans; Indomethacin; Male; Permeability; Rabb | 1993 |
Indomethacin-associated gastrointestinal hemorrhage in a dog.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Duodenal Diseases; Female; Gastritis; Gastrointes | 1972 |